Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 13, 2024, ProMIS Neurosciences Inc. (the "Company") held its 2024 annual meeting of shareholders (the “Annual Meeting”). The shareholders considered four proposals, each of which is described in more detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 25, 2024. Of the 18,961,116 Common Shares, no par value per share (the “Common Shares”), outstanding as of the record date, 7,811,371 Common Shares hares, or approximately 41.19%, were present or represented by proxy at the Annual Meeting. Set forth below are the results of the matters submitted for a vote of shareholders at the Annual Meeting.
Proposal No. 1: Election of seven nominees to serve as directors until the 2025 annual meeting of shareholders or until his or her successor has been duly elected and qualified or until his or her earlier resignation or removal. The votes were cast as follows by holders of Common Shares:
| | | | | | |
Name | | Votes For | | Votes Withheld | | |
Eugene Williams | 4,149,424 | | 515,817 | | |
Neil Cashman, M.D. | 4,605,556 | | 59,685 | | |
Patrick D. Kirwin | 4,524,061 | | 141,180 | | |
Joshua Mandel-Brehm | 4,491,624 | | 173,617 | | |
Maggie Shafmaster, Ph.D,J.D. | 4,493,208 | | 172,033 | | |
Neil K. Warma | 4,399,117 | | 266,124 | | |
William Wyman | 4,018,983 | | 646,258 | | |
Broker Non-Votes: 3,228,732
All seven nominees were elected.
Proposal No. 2: A special resolution authorizing the directors of the Company to set the number of directors of the Company for the ensuing year at seven directors and authorizing the directors of the Company to set the number of directors within the maximum and minimum numbers provided for in the articles of the Company by way of
resolution from time to time.
| | | | | | |
| Votes For | Votes Against | Abstained |
Authorization to set the number of directors of the Corporation at seven and to set the number of directors within the minimum and maximum numbers provided in the articles by way of a resolution from time to time | 7,406,478 | | 70,497 | | 334,396 | |
Proposal No. 3: Ratification of the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. The votes were cast as follows by holders of Common Shares:
| | | | | | |
| Votes For | Votes Against | Abstained |
Ratification of appointment of Baker Tilly US, LLP | 7,703,063 | | 64,256 | | 44,052 | |
Proposal No. 4: An ordinary resolution approving the unallocated stock options under the Company 's stock option plan.
| | | | | | |
| Votes For | Votes Against | Abstained |
Approval of unallocated stock options | 3,867,633 | | 451,204 | | 346,404 | |
Broker non-votes: 3,228,732
No other matters were submitted to or voted on by the Company’s shareholders at the Annual Meeting.